Table 1.
Treatment outcome and patient satisfaction after topical application of CPS1 solution for cutaneous warts
| Children (age <18) | Adults (age ≥18) | Total | p Value | |
|---|---|---|---|---|
| Clearance of warts# | n = 52 | n = 83 | n = 135 | <.01* |
| Complete | 45 (86.5) | 52 (62.7) | 97 (71.9) | |
| Partial | 2 (3.9) | 20 (24.1) | 22 (16.3) | |
| None | 5 (9.6) | 11 (13.2) | 16 (11.8) | |
| Number of treatments with CPS1 solution~ | n = 52 | n = 83 | n = 135 | <.01* |
| 1–3 | 34 (65.4) | 31 (37.3) | 65 (48.1) | |
| ≥ 4 | 18 (34.6) | 52 (62.7) | 70 (51.9) | |
| Number of treatments with CPS1 solution~, median (IQR) | 3.0 (2.0–4.0) | 4.0 (3.0–5.0) | 4.0 (2.0–5.0) | <.01* |
| Duration before clearance of warts after onset treatment with CPS1 in months#, median (IQR) | 3.0 (1.6–6.0) | 5.0 (3.0–6.0) | 4.0 (2.5–6.0) | .02* |
| Recurrence of warts# | n = 47 | n = 72 | n = 119 | .3 |
| Yes (complete/partial) | 5 (10.6) | 14 (19.4) | 19 (16.0) | |
| No | 42 (89.4) | 58 (80.6) | 100 (84.0) | |
| Patient global assessment of treatment effect∞ | n = 51 | n = 83 | n = 134 | .01* |
| Good, very good or excellent | 45 (88.2) | 57 (68.7) | 102 (76.1) | |
| Bad or reasonable | 6 (11.8) | 26 (31.3) | 32 (23.9) | |
| Patient satisfaction score∞, median (IQR) | 9.0 (7.8–10.0) | 8.0 (5.1–9.7) | 8.5 (6.0–9.95) | <.01* |
Note: Data are n (%) unless stated otherwise. Abbreviations: CPS1, cantharidin 1% podophyllin 2% salicylic acid 30%; IQR, interquartile range; n, total number of patients; *, p value <.05; ~, data obtained from patients' electronic record; #, data obtained from patients' electronic record and survey; ∞, data obtained from survey.